Are TRT side effects really just temporary? What the data says

What did @invitewellnessllc actually say?

The creator's core argument is straightforward: most side effects from testosterone replacement therapy are temporary, concentrated in the early dose-optimization window, and once your levels stabilize, it's "pretty much smooth sailing." They also pushed back on a real phenomenon in TRT communities, where patients attribute unrelated symptoms to their injections. Tinnitus and foot fungus were the examples they chose. They framed this as a clinical educator speaking from practice, not just social media speculation.

To their credit, they mentioned that they walk through potential side effects with patients at the initiation visit. That's the right approach. Patient counseling before starting TRT reduces anxiety and improves treatment adherence, which is well documented. The puberty analogy, comparing hormone fluctuations during TRT adjustment to adolescent changes, is a reasonable lay-person frame, even if it glosses over some meaningful differences between endogenous puberty and exogenous testosterone administration.

Does the science back this up?

Partially, yes. But "smooth sailing" is doing a lot of heavy lifting here, and the evidence doesn't fully support that framing for all patients.

Short-term side effects during TRT initiation, including acne, increased hematocrit, fluid retention, and mood fluctuations, do tend to peak early and resolve with dose adjustment for many patients. A 2017 study by Bhasin et al. in the New England Journal of Medicine found that testosterone-related adverse events were dose-dependent and often manageable, but they didn't disappear entirely for all participants. Erythrocytosis, meaning elevated red blood cell count, is a persistent concern, not a transient one. The Testosterone Trials, a coordinated series of trials published across multiple journals between 2016 and 2018, found that hematocrit elevation required monitoring throughout treatment, not just in the early weeks.

The claim that side effects are "mostly transient" holds for some, but cardiovascular risk, sleep apnea exacerbation, and fertility suppression are not adjustment-phase issues. They can persist or emerge over longer treatment timelines. The puberty analogy also breaks down here: adolescent testosterone rises gradually and endogenously, while TRT involves injecting supraphysiologic peaks followed by troughs, which is a different pharmacokinetic reality.

What did they get wrong (or right)?

They got the attribution problem right. TRT forums are genuinely filled with patients blaming testosterone for everything from seasonal allergies to bad luck. That's not a small issue. Miscausal attribution can lead patients to stop a therapy that's actually working, or to mask symptoms that deserve their own clinical attention. The creator is correct to call this out.

Where the video falls short is in the framing of side effects as mostly an early, temporary phase. That's accurate for a subset of effects, but it creates a reassurance bias that could leave patients unprepared for longer-term monitoring requirements. Hematocrit checks, lipid panels, prostate-specific antigen monitoring, and blood pressure tracking are ongoing, not just startup concerns. Presenting TRT as "smooth sailing" after the adjustment phase undersells the real clinical management this therapy requires.

There's also no mention of fertility suppression, which is a significant and often irreversible consequence for men who haven't completed their families. That omission matters, particularly on a platform like TikTok where younger men are increasingly interested in TRT.

What should you actually know?

TRT is a legitimate medical therapy for men with clinically confirmed hypogonadism, and it does carry real benefits. But the framing that side effects are mostly a startup problem, followed by smooth sailing, isn't the complete picture your prescriber should be giving you.

The real checklist looks like this:

• Erythrocytosis (elevated hematocrit) requires ongoing blood monitoring, not just early checks. Bhasin et al. (2018, New England Journal of Medicine) identified this as one of the most consistent dose-dependent adverse effects.
• Fertility suppression via suppression of the hypothalamic-pituitary-gonadal axis is a persistent effect. It doesn't resolve after an adjustment phase. Men who want biological children need to discuss this before starting, not after.
• Sleep apnea can be worsened by exogenous testosterone and may not emerge until months into therapy.
• Cardiovascular effects remain under active study. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) found TRT was non-inferior to placebo for major cardiovascular events in men with hypogonadism and elevated cardiovascular risk, but this doesn't mean the risk conversation ends at initiation.

If a provider frames TRT as a rough start followed by no real concerns, ask about their hematocrit monitoring protocol. That question alone will tell you a lot about how seriously they're managing your care.